Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Cancer Management and Research|January 30, 2015
Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal diseaseLudimila Cavalcante, Asim Amin, Jose LutzkyFrontiers in Immunology|August 8, 2025
Emerging IO checkpoints in gastrointestinal oncologyAlireza Tojjari, Anwaar Saeed, Ludimila CavalcanteCancers|February 13, 2025
Adoptive T Cell Therapy Targeting MAGE-A4Kapil Chandora, Akshay Chandora, Anwaar Saeed, et al.Current Pharmaceutical Design|October 25, 2014
Combined modality therapy in pancreatic adenocarcinoma: review and updates on a controversial issueLudimila Cavalcante, David P Kelsen, Kenneth H YuJournal of Hematology & Oncology|September 14, 2022
Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cellsGary Shaw, Ludimila Cavalcante, Francis J Giles, et al.American Journal of Clinical Dermatology|July 2, 2018
Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant MelanomaLudimila Cavalcante, Akansha Chowdhary, Jeffrey A Sosman, et al.Biology|August 6, 2021
GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory PropertiesRobin Park, Andrew L Coveler, Ludimila Cavalcante, et al.Journal of Immunotherapy and Precision Oncology|August 28, 2023
Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New EraMaluki Radford, Hassan Abushukair, Stijn Hentzen, et al.Cancers|November 25, 2023
Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial ApproachesAlireza Tojjari, Anwaar Saeed, Arezoo Sadeghipour, et al.Cancers|October 14, 2023
SLAM Modification as an Immune-Modulatory Therapeutic Approach in CancerAlireza Tojjari, Francis J Giles, Maysa Vilbert, et al.Pageof 4